Roth Capital analyst Bill Kirk maintained a “Buy” rating and $5.00 target on High Tide (High Tide Stock Quote, Chart, News, Analysts, Financials NASDAQ:HITI), citing record Remexian volumes and a new C$40-million financing package. High Tide is a Canadian retailer, distributor and e-commerce provider of regulated cannabis products and related accessories. Kirk said Remexian sold […]
Cryoport stock is a buy, this analyst saysRoth Capital analyst Richard Baldry maintained a “Buy” rating and $15.00 target on Cryoport (Cryoport Stock Quote, Chart, News, Analysts, Financials NASDAQ:CYRX) after what he called a good first quarter, with revenue ahead of his forecast and Adjusted EBITDA losses narrowing. Cryoport reported revenue of $47.8-million, up 16.5% year-over-year after adjusting for the CryoPDP divestiture […]